Jun Yatsunami

1.5k total citations
40 papers, 1.2k citations indexed

About

Jun Yatsunami is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jun Yatsunami has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Jun Yatsunami's work include Angiogenesis and VEGF in Cancer (6 papers), Peptidase Inhibition and Analysis (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Jun Yatsunami is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Peptidase Inhibition and Analysis (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Jun Yatsunami collaborates with scholars based in Japan, United Kingdom and United States. Jun Yatsunami's co-authors include Hirota Fujiki, Masami Suganuma, Atsumasa Komori, Sachiko Okabe, Nobuko Tsuruta, Saori Abe, Nobuyuki Hara, Koichi Takayama, Shinichiro Hayashi and Masayuki Kawasaki and has published in prestigious journals such as Cancer, Biochemical and Biophysical Research Communications and Carcinogenesis.

In The Last Decade

Jun Yatsunami

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Yatsunami Japan 19 519 276 254 164 161 40 1.2k
Ada Elgavish United States 22 797 1.5× 286 1.0× 368 1.4× 77 0.5× 208 1.3× 76 2.0k
Shigeru Yoshizawa Japan 15 240 0.5× 184 0.7× 213 0.8× 311 1.9× 49 0.3× 37 1.1k
Masayoshi Kanisawa Japan 23 600 1.2× 215 0.8× 64 0.3× 163 1.0× 265 1.6× 99 1.8k
Don A. Delker United States 21 684 1.3× 353 1.3× 208 0.8× 133 0.8× 327 2.0× 53 1.8k
Jianghong Wu China 23 901 1.7× 317 1.1× 116 0.5× 40 0.2× 379 2.4× 49 1.6k
Lili Duan China 22 840 1.6× 159 0.6× 76 0.3× 69 0.4× 248 1.5× 103 1.5k
G. Timothy Bowden United States 29 1.2k 2.4× 429 1.6× 85 0.3× 21 0.1× 477 3.0× 57 2.2k
Félix V. Vega Spain 17 488 0.9× 101 0.4× 52 0.2× 77 0.5× 57 0.4× 26 1.1k
Yongliang Zhu China 20 651 1.3× 227 0.8× 73 0.3× 34 0.2× 276 1.7× 62 1.2k
Edward J. Dudek United States 16 775 1.5× 79 0.3× 29 0.1× 328 2.0× 149 0.9× 23 1.5k

Countries citing papers authored by Jun Yatsunami

Since Specialization
Citations

This map shows the geographic impact of Jun Yatsunami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Yatsunami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Yatsunami more than expected).

Fields of papers citing papers by Jun Yatsunami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Yatsunami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Yatsunami. The network helps show where Jun Yatsunami may publish in the future.

Co-authorship network of co-authors of Jun Yatsunami

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Yatsunami. A scholar is included among the top collaborators of Jun Yatsunami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Yatsunami. Jun Yatsunami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yatsunami, Jun, et al.. (1999). Inhibitory effects of roxithromycin on tumor angiogenesis, growth and metastasis of mouse B16 melanoma cells. Clinical & Experimental Metastasis. 17(2). 119–124. 17 indexed citations
2.
Yatsunami, Jun, Nobuko Tsuruta, Shigehisa Aoki, et al.. (1999). Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells. Cancer Letters. 147(1-2). 17–24. 17 indexed citations
3.
Yatsunami, Jun, Masaki Tominaga, Shigehisa Aoki, et al.. (1999). Antiangiogenic and antitumor effects of 14-membered ring macrolides on mouse B16 melanoma cells. Clinical & Experimental Metastasis. 17(4). 359–365. 36 indexed citations
4.
Yatsunami, Jun, et al.. (1998). Inhibition of tumor angiogenesis by roxithromycin, a 14-membered ring macrolide antibiotic. Cancer Letters. 131(2). 137–143. 26 indexed citations
5.
Nakanishi, Yoichi, Koichi Takayama, Masayuki Kawasaki, et al.. (1997). Phase II Trial of Dose Intensification with Cisplatin and Carboplatin Plus Vindesine in Patients with Inoperable Non-Small Cell Lung Cancer. American Journal of Clinical Oncology. 20(4). 393–397. 3 indexed citations
6.
Yatsunami, Jun, et al.. (1997). Clarithromycin is a potent inhibitor of tumor-induced angiogenesis. Research in Experimental Medicine. 197(4). 189–197. 35 indexed citations
7.
Yatsunami, Jun, Nobuko Tsuruta, Kenichi Ogata, et al.. (1997). Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung. Cancer Letters. 120(1). 101–108. 72 indexed citations
8.
Bai, Fen, Masayuki Kawasaki, Koichi Takayama, et al.. (1996). Immunohistochemical expression of glutathione S-transferase-π can predict chemotherapy response in patients with nonsmall cell lung carcinoma. Cancer. 78(3). 416–421. 68 indexed citations
9.
Nishizaki, Takashi, Katsuhiko Yanaga, Yuji Soejima, et al.. (1996). Tuberculosis following liver transplantation: report of a case and review of the literature. Transplant International. 9(6). 589–592. 15 indexed citations
10.
Pei, Xin‐Hai, Yoichi Nakanishi, Koichi Takayama, et al.. (1996). Granulocyte-colony stimulating factor promotes invasion by human lung cancer cell lines in vitro. Clinical & Experimental Metastasis. 14(4). 351–357. 14 indexed citations
11.
Nakanishi, Yoichi, Kentaro Wakamatsu, Y Nomoto, et al.. (1996). Empyema Following the Percutaneous Instillation of Antifungal Agents in Patients with Aspergillosis.. Internal Medicine. 35(8). 657–659. 5 indexed citations
12.
Nakanishi, Yoichi, et al.. (1994). [Percutaneous intracavitary treatment of pulmonary aspergilloma-clinical efficacy and prognosis].. PubMed. 32(6). 538–43. 2 indexed citations
13.
Suganuma, Masami, S Yoshizawa, Jun Yatsunami, et al.. (1993). Mechanisms of Action of New Antitumor Promoters. PubMed. 61. 317–323. 2 indexed citations
14.
Yatsunami, Jun, et al.. (1993). Hyperphosphorylation of cytokeratins by okadaic acid class tumor promoters in primary human keratinocytes.. PubMed. 53(5). 992–6. 27 indexed citations
15.
Fujiki, Hirota, Seiji Yoshizawa, Takahiko Horiuchi, et al.. (1992). Anticarcinogenic effects of (−)-epigallocatechin gallate. Preventive Medicine. 21(4). 503–509. 119 indexed citations
16.
Tatematsu, Masae, Jun Yatsunami, Shigeru Yoshizawa, et al.. (1992). An alternative theory of tissue specificity by tumor promotion of okadaic acid in glandular stomach of SD rats. Carcinogenesis. 13(10). 1841–1845. 47 indexed citations
17.
Ohta, Tetsuya, et al.. (1992). Hyperphosphorylation of cytokeratins 8 and 18 by microcystin-LR, a new liver tumor promoter, in primary cultured rat hepatocytes. Carcinogenesis. 13(12). 2443–2447. 104 indexed citations
18.
Yatsunami, Jun, Hirota Fujiki, Masami Suganuma, et al.. (1991). Vimentin is hyperphosphorylated in primary human fibroblasts treated with okadaic acid. Biochemical and Biophysical Research Communications. 177(3). 1165–1170. 61 indexed citations
19.
Nakanishi, Masayuki, Katsuro Yagawa, Shinichiro Hayashi, et al.. (1991). Plasma Thrombosis-Inducing Activity in 120 Patients with Primary Lung Cancer. Oncology. 48(4). 297–300. 7 indexed citations
20.
Yatsunami, Jun, Hirota Fujiki, Masami Suganuma, et al.. (1991). Binding competition of okadaic acid derivatives to anti-okadaic acid antibody. Toxicon. 29(11). 1409–1412. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ada Elgavish Breakdown of academic impact, for papers by Shigeru Yoshizawa Breakdown of academic impact, for papers by Masayoshi Kanisawa Breakdown of academic impact, for papers by Don A. Delker Breakdown of academic impact, for papers by Jianghong Wu Breakdown of academic impact, for papers by Lili Duan Breakdown of academic impact, for papers by G. Timothy Bowden Breakdown of academic impact, for papers by Félix V. Vega Breakdown of academic impact, for papers by Yongliang Zhu Breakdown of academic impact, for papers by Edward J. Dudek
Rankless by CCL
2026